Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
Copenhagen - Delayed Quote DKK

ChemoMetec A/S (CHEMM.CO)

Compare
425.00
-39.60
(-8.52%)
At close: April 4 at 4:59:38 PM GMT+2
Currency in DKK All numbers in thousands
Download
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Total Revenue
407,870
407,870
444,401
428,391
281,127
Cost of Revenue
40,275
40,275
32,901
44,138
27,783
Gross Profit
367,595
367,595
411,500
384,253
253,344
Operating Expense
198,631
198,631
180,860
181,488
136,490
Operating Income
168,964
168,964
230,640
202,765
116,854
Net Non Operating Interest Income Expense
7,892
7,892
1,364
-1,508
-830
Pretax Income
176,586
176,586
230,360
203,220
112,733
Tax Provision
40,302
40,302
51,693
43,751
24,379
Net Income Common Stockholders
136,284
136,284
178,667
159,469
88,354
Diluted NI Available to Com Stockholders
136,284
136,284
178,667
159,469
88,354
Basic EPS
7.83
--
10.27
9.16
5.08
Diluted EPS
7.83
--
10.27
9.16
5.08
Basic Average Shares
17,402.48
--
17,402.48
17,402.48
17,402.48
Diluted Average Shares
17,402.48
--
17,402.48
17,402.48
17,402.48
Total Operating Income as Reported
--
--
--
202,854
116,023
Total Expenses
238,906
238,906
213,761
225,626
164,273
Net Income from Continuing & Discontinued Operation
136,284
136,284
178,667
159,469
88,354
Normalized Income
136,282.46
136,282.46
178,728.30
159,398.35
89,005.50
Interest Income
8,075
8,075
2,457
9
88
Interest Expense
180
180
1,088
1,482
918
Net Interest Income
7,892
7,892
1,364
-1,508
-830
EBIT
176,766
176,766
231,448
204,702
113,651
EBITDA
193,977
193,977
251,838
224,829
133,258
Reconciled Cost of Revenue
40,275
40,275
32,901
44,138
27,783
Reconciled Depreciation
17,211
17,211
20,390
20,038
19,607
Net Income from Continuing Operation Net Minority Interest
136,284
136,284
178,667
159,469
88,354
Total Unusual Items Excluding Goodwill
2
2
-79
90
-831
Total Unusual Items
2
2
-79
90
-831
Normalized EBITDA
193,975
193,975
251,917
224,739
134,089
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0.46
0.46
-17.70
19.35
-179.50
6/30/2021 - 12/18/2006

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

GN.CO GN Store Nord A/S
91.18
-8.38%
 
AMBU-B.CO Ambu A/S
108.20
-1.23%
 
DEMANT.CO Demant A/S
216.80
-2.61%
 
SMSMED.CO Scandinavian Medical Solutions A/S
4.1300
+3.25%
 
LAB Standard BioTools Inc.
1.0700
0.00%
 
GNNDY GN Store Nord A/S
39.75
-0.38%
 
GETI-B.ST Getinge AB (publ)
194.50
-5.31%
 
MXCT MaxCyte, Inc.
2.4500
-5.77%
 
RPID Rapid Micro Biosystems, Inc.
2.1900
-14.12%
 
CLPT ClearPoint Neuro, Inc.
11.03
-9.11%